Lichen planus is more of a chronic discomfort than a serious health concern. However, people with the oral form have a slightly higher risk of developing oral cancer. Lichen planus is a group of ...

Lichen planus is a frustrating and uncomfortable skin condition, but with the right treatments and lifestyle changes, you can manage its symptoms and reduce the risk of it spreading. Lichen planus is ...

Please provide your email address to receive an email when new articles are posted on . At week 28, 88% of patients treated with combination therapy achieved 75% disease severity reduction vs. 47% on ...

PITTSBURGH, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical-stage biotechnology company dedicated to addressing serious diseases with significant unmet needs, ...

The "Clinical Snapshot" series provides a concise examination of a clinical presentation including history, treatment, patient education, and nursing measures. Using the format here, you are invited ...

Lipella Pharmaceuticals Inc. announced that the FDA has approved an Expanded Access Program for LP-310, an oral rinse formulated to treat oral lichen planus (OLP), a debilitating condition affecting ...

A survey of US dermatologists revealed low screening rates for common comorbidities in patients with lichen planus (LP), with significant reliance on topical treatments. An anonymous survey with ...

Please provide your email address to receive an email when new articles are posted on . All patients treated with baracitinib for lichen planus had a response at week 12. After 1 week of treatment, 37 ...